Conferences and Events

^{Emil J Freireich Hematology Grand Rounds}

The MD Anderson Cancer Center Emil J Freireich Hematology Grand Rounds now has a virtual format. This series will highlight the incredible research taking place at MD Anderson Cancer Center while showcasing leaders from our research community, in an effort to remain engaged and inspired during the COVID-19 pandemic. Hosted by the Leukemia department in collaboration with the Lymphoma/Myeloma department, and Stem Cell Transplantation and Cellular Therapy department, we aim to strengthen the connections between the scientific and medical community at MD Anderson Cancer Center, our colleagues, patients and friends from around the world.

After attending this activity, the target audience of physicians from Leukemia, Lymphoma/Myeloma, Stem Cell Transplantation and Research Staff, Nurses, Data Coordinators, Laboratory Staff, Post-Doctoral Fellows, Instructors, and Research Staff in Lab should be able to:

Assess clinical and translational research in lymphoma and plasma cell dyscrasia (knowledge);
Increase collaboration between disciplines regarding lymphoma and plasma cell dyscrasia (knowledge, competence, performance);
Update knowledge and collaboration in trials and research (knowledge, competence, performance);
Accelerate the speed of translational research and clinical trials to achieve better patient outcomes (knowledge, competence, performance, patient outcomes);

The series will occur every Wednesday at 8 a.m. CST and will consist of a 45-minute presentation followed by a Q&A session.

Event Details

Time: 8 - 9 a.m. CST

Recurrence: Wednesdays

Virtual Platform: WebEx meeting - Meeting Details
Meeting ID: 828 5512 6524
Password: 123283

Audio: Tap to call in from a mobile device (attendees only)

1404-397-1527 United States Toll
Toll-free calling restrictions

Audience: Internal & external colleagues from around the world

Organized by: The Leukemia Department under the direction of Farhad Ravandi, MD. For more information, contact fravandi@mdanderson.org.

Special thanks to Shannon Bailey, Dr. Ravandi's faculty support, for coordinating the virtual weekly seminars.

Upcoming Presentations

July 21, 2021 -- Hagop M. Kantarjian, M.D.
August 4, 2021 -- Jan Burger, M.D., Ph.D.
August 11, 2021 -- Torsten Haferlach, M.D., Ph.D.
August 18, 2021 -- Elisa Ten Hacken, Ph.D.
September 1, 2021 -- Tapan Kadia. M.D.
September 8, 2021 -- Christoph Rollig, M.D.
September 15, 2021 -- David Spencer, M.D.

Previous Recordings

"Myeloproliferative Neoplasms (MPN): From ASH 2019 to EHA 2020"

Watch recording (includes captioning)

Srdan Verstovsek, M.D., Ph.D.
“Assessment of minimal residual/measurable acute myeloid leukemia by multi-parameter flow cytometry”

Watch recording (includes captioning)

Sa Wang, M.D.
“Updates from the world of FLT3”

Watch recording (includes captioning)

Mark Levis, M.D., Ph.D.
“Management of Acute Myeloid Leukemia in 2020”

Watch recording (includes captioning)

Farhad Ravandi, M.D.
“Turning on an Apoptotic Switch in Leukemia: BCL-2 and Beyond”

Watch recording (includes captioning)

Marina Y. Konopleva, M.D., Ph.D.
“Management of Philadelphia chromosome positive acute lymphoblastic leukemia-The Italian perspective”

Watch recording (includes captioning)

Giovanni Martinelli, M.D.
“Overcoming adaptive therapy resistance in leukemia”

Watch recording (includes captioning)

Daniel Starczynowski, Ph.D.
“Fractionated Busulfan Conditioning Regimen: Progress?”

Watch recording (includes captioning)

Uday Popat, M.D.
“Hematopoietic stem cells in normal, stressed and malignant hematopoiesis”

Watch recording (includes captioning)

Simona Colla, Ph.D.
"Best of ALL 2021"

Watch recording (includes captioning)

Elias Jabbour, M.D.
“CLL ASH 2020 Update”

Watch recording (includes captioning)

William Wierda, M.D., Ph.D.
"Update on Myeloproliferative Neoplasms from ASH 2020"

Watch recording (includes captioning)

Srdan Verstovsek, M.D., Ph.D.
“Treatment of MDS in 2021: an ASH update”

Watch recording (includes captioning)

Guillermo Garcia-Manero, M.D.
“Where do we go with FLT3 inhibitors from here”

Watch recording (includes captioning)

Keith Pratz, M.D.
"Recently approved drugs in the frontline treatment of AML | Can biology refine indications?"

Watch recording (includes captioning)

Stéphane de Botton M.D., Ph.D.
"Progress in Leukemia 2021"

Watch recording (includes captioning)

Hagop M. Kantarjian, M.D.
"AMLSG: Clinical and translational research projects“

Watch recording (includes captioning)

Prof. Dr. Konstanze Döhner
"Evolution of Epigenetic Therapies in MDS & AML”

Watch recording (includes captioning)

Hagop M. Kantarjian, M.D.
“AML from an Australian Perspective”

Watch recording (includes captioning)

Andrew Wei, M.D.
"An Update on IDH1/2- mutant AML"

Watch recording (includes captioning)

Courtney D. DiNardo, M.D., MSCE
“Chimeric Antigen Receptor T-cell Therapy for Hematologic Malignancies”

Watch recording (includes captioning)

Jim Kochenderfer, M.D.
"Biology and novel therapy of AML with 3q26.2 lesions and EVI1 overexpression”

Watch recording (includes captioning)

Kapil N. Bhalla, M.D., F.A.C.P.
"Hairy Cell Leukemia and the BRAF-V600E Mutation: A Journey Through Genetics, Biology, Diagnosis, and Therapy"

Watch recording (includes captioning)

Enrico Tiacci, M.D.
"Mechanisms of Bone Marrow Failure in Human Acute Myeloid Leukemia & Therapeutic Interventions"

Watch recording (includes captioning)

Tian Yi Zhang, M.D., Ph.D.
“Primers on eosinophilic hematologic neoplasms”

Watch recording (includes captioning)

Andreas Reiter, M.D.
“Improving outcomes in patients allografted for Acute Myeloid Leukemia”

Watch recording (includes captioning)

Prof. Charles Craddock CBE, FRCP (UK), FRCPath, DPhil, FMedSci